Evaluation of intraductal meibomian gland probing on meibomian gland obstruction

Evaluation of intraductal meibomian gland probing on meibomian gland obstruction - Evaluation of intraductal meibomian gland probing on meibomian gland obstruction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014463

Enrollment

Registered

2014-07-03

Start date

2014-07-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

meibomian gland obstruction

Interventions

intraductal meibomian gland probing

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with meibomian gland obstruction

Exclusion criteria

Exclusion criteria: severe ocular surface disease patient who had ocular surgery within 6 months people who have hemostatic dysfunction

Design outcomes

Primary

Measure	Time frame
subjective symptom, fluorescein staining score, breakup time, DR1, Mibography, meibum grade	—

Countries

Japan

Contacts

Public ContactMotoko Kawashima

Keio University School of Medicine Ophthalmology

motoko326@gmail.com81333531211(63954)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026